TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16056126

Group type: EXPERIMENTAL
Intervention: Prenatal alcohol exposure
Number of subjects: 42

Group type: COMPARATOR
Intervention: Normally developing individuals
Number of subjects: 42
Study: 11991313

Group type: EXPERIMENTAL
Intervention: Upbeat music group
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Relaxing music group
Number of subjects: 45

Group type: COMPARATOR
Intervention: No music group
Number of subjects: 45
Study: 9583546

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intrapleural analgesia (IPA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 50
Study: 7651642

Group type: EXPERIMENTAL
Intervention: Motivational brochures and tracking system
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual contact procedures (Control)
Number of subjects: 100
Study: 2668706

Group type: EXPERIMENTAL
Intervention: CIAC Scheme (domiciliary care)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional hospital antenatal care (control)
Number of subjects: 60
Study: 1052683

Group type: EXPERIMENTAL
Intervention: Step indentations of the index finger tip via mechanostimulator
Number of subjects: 0
Study: 31707940

Group type: EXPERIMENTAL
Intervention: Black vignette
Number of subjects: 422

Group type: COMPARATOR
Intervention: White vignette
Number of subjects: 422
Study: 29933716

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 171
Study: 26977623

Group type: EXPERIMENTAL
Intervention: Tenoten
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pain relievers (Control)
Number of subjects: 60
Study: 24624990

Group type: EXPERIMENTAL
Intervention: school‐led FRIENDS
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: health care‐led FRIENDS
Number of subjects: 41

Group type: COMPARATOR
Intervention: treatment as usual
Number of subjects: 41
Study: 22184409

Group type: EXPERIMENTAL
Intervention: 2 cycles of ICE (if negative FDG-PET scan) followed by HDT/ASCT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4 biweekly doses of gemcitabine, vinorelbine, and liposomal doxorubicin (if positive FDG-PET scan)
Number of subjects: 0
Study: 19815600

Group type: COMPARATOR
Intervention: Complementary and alternative medicine (CAM) therapies
Number of subjects: 45

Group type: COMPARATOR
Intervention: Trials failing to meet validity criteria
Number of subjects: 45
Study: 17481702

Group type: EXPERIMENTAL
Intervention: Optical Detection System (ODS) used as an adjunct to colposcopy
Number of subjects: 193

Group type: COMPARATOR
Intervention: Colposcopy alone
Number of subjects: 193
Study: 14693671

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 76
Study: 12192196

Group type: COMPARATOR
Intervention: Epinephrine (5 to 10 mL of 1:10,000 epinephrine)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Fibrin sealant (4 mL)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Epinephrine and Fibrin sealant
Number of subjects: 51
Study: 9932950

Group type: EXPERIMENTAL
Intervention: Clinic room presentation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conference room presentation
Number of subjects: 100
Study: 9304384

Group type: EXPERIMENTAL
Intervention: Total sialic acid level in blood
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Haptoglobin level in blood
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ceruloplasmin level in blood
Number of subjects: 20
Study: 2184993

Group type: COMPARATOR
Intervention: Lower-limb exercise training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Combined exercise training (upper-limb + lower-limb)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Upper-limb exercise training
Number of subjects: 28
Study: 348228

Group type: EXPERIMENTAL
Intervention: Suprapubic puncture site
Number of subjects: 98

Group type: COMPARATOR
Intervention: Nuchal puncture site
Number of subjects: 98
Study: 31136247

Group type: EXPERIMENTAL
Intervention: Caregiver operational competency and AAC system buy-in reported by parents and teachers
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: AAC device use tracked via logging feature
Number of subjects: 29
Study: 27875526

Group type: EXPERIMENTAL
Intervention: Caphosol (topically administered, rinsed orally four times daily from initiation of conditioning through day +20)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo saline rinses (four times daily from initiation of conditioning through day +20)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Caphosol
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 26553688

Group type: EXPERIMENTAL
Intervention: PsA‐TT (MenAfriVac) vaccine
Number of subjects: 360

Group type: COMPARATOR
Intervention: Quadrivalent polysaccharide vaccine (PsACWY)
Number of subjects: 360
Study: 23707040

Group type: EXPERIMENTAL
Intervention: Breast milk odor
Number of subjects: 50

Group type: COMPARATOR
Intervention: Formula milk odor
Number of subjects: 50
Study: 21621834

Group type: EXPERIMENTAL
Intervention: NV1FGF at 0.2 mg/mL
Number of subjects: 525

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 525
Study: 19615809

Group type: EXPERIMENTAL
Intervention: Ovoil (Vitrolife, Kungsbacka, Sweden)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Mineral Oil (CryoBioSystem, L'Aigle, France)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Liquid Paraffin (Medicult, Lyon, France)
Number of subjects: 500
Study: 17540966

Group type: EXPERIMENTAL
Intervention: Rehabilitation therapy with investigational motor cortex stimulation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Rehabilitation therapy without investigational motor cortex stimulation
Number of subjects: 24
Study: 15130570

Group type: EXPERIMENTAL
Intervention: Individualised acupuncture (up to 10 treatments)
Number of subjects: 148
Study: 11811505

Group type: EXPERIMENTAL
Intervention: Enamel matrix proteins (EMD)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Guided tissue regeneration (GTR) with bioabsorbable membranes
Number of subjects: 12
Study: 9713783

Group type: EXPERIMENTAL
Intervention: 2% dorzolamide three times daily
Number of subjects: 383

Group type: COMPARATOR
Intervention: Placebo three times daily
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: 2% dorzolamide twice daily
Number of subjects: 383

Group type: COMPARATOR
Intervention: Placebo twice daily
Number of subjects: 383
Study: 1483485

Group type: EXPERIMENTAL
Intervention: Sinemet CR (200 mg levodopa/50 mg carbidopa)
Number of subjects: 8
Study: 3902498

Group type: EXPERIMENTAL
Intervention: Salbutamol 200 micrograms
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Salbutamol 400 micrograms
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 200 micrograms
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of oxitropium bromide (200 micrograms) and salbutamol (200 micrograms)
Number of subjects: 12
Study: 30152245

Group type: EXPERIMENTAL
Intervention: Oxygen-guided training (n=8)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Pain-based training (n=10)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 18
Study: 30613073

Group type: EXPERIMENTAL
Intervention: Horizontal vibration exercise (HVE)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Vertical vibration exercise (VVE)
Number of subjects: 28
Study: 27084704

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG + Bifidobacterium BB-12 (LGG-BB12)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri RC-14 + Lactobacillus rhamnosus GR-1 (RC14-GR1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: RC14-GR1 + placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: LGG-BB12 + placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Probiotics (LGG-BB12 or RC14-GR1)
Number of subjects: 0
Study: 25707826

Group type: EXPERIMENTAL
Intervention: Lingual fixed orthodontic appliances
Number of subjects: 52

Group type: COMPARATOR
Intervention: Labial fixed orthodontic appliances
Number of subjects: 52
Study: 22866909

Group type: EXPERIMENTAL
Intervention: Vaginal natural progesterone, 200 mg daily from 22 to 34 weeks gestation
Number of subjects: 800

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800
Study: 19386947

Group type: COMPARATOR
Intervention: Warfarin (25 mg) alone
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Warfarin (25 mg) with nitazoxanide (500 mg, twice daily for 6 days)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Warfarin (25 mg) alone and Warfarin (25 mg) with nitazoxanide (500 mg, twice daily for 6 days)
Number of subjects: 14
Study: 17697099

Group type: EXPERIMENTAL
Intervention: Computerized tests (Cognitive Drug Research)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Pencil-and-paper tests (Wechsler Adult Intelligence and Memory Scales)
Number of subjects: 81
Study: 15681761

Group type: COMPARATOR
Intervention: Keyhole limpet hemocyanin (KLH) feeding on days 1 to 5 and 11 to 15, followed by subcutaneous immunization with KLH on day 26 and a booster on day 35.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Keyhole limpet hemocyanin (KLH) feeding and immunization protocol as described.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Analysis of genetic factors in tolerance induction.
Number of subjects: 46
Study: 11587159

Group type: EXPERIMENTAL
Intervention: Trandolapril (2 mg oral for 12 weeks)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg oral for 12 weeks)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo (4-week period before randomization)
Number of subjects: 89
Study: 9843101

Group type: EXPERIMENTAL
Intervention: CAP (cyclophosphamide, doxorubicin, and cisplatin)
Number of subjects: 1526

Group type: COMPARATOR
Intervention: Single-agent carboplatin
Number of subjects: 1526
Study: 7604352

Group type: EXPERIMENTAL
Intervention: Automated percutaneous lumbar discectomy (APLD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Microdiscectomy
Number of subjects: 0
Study: 2235228

Group type: EXPERIMENTAL
Intervention: Prolonged maternal fluid supplementation (25% increase in fluids above baseline for 7 days)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Baseline fluid intake
Number of subjects: 19

Group type: COMPARATOR
Intervention: Increased fluid intake
Number of subjects: 19
Study: 391678

Group type: EXPERIMENTAL
Intervention: Essaven capsules (3 X 2 capsules per day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 31706140

Group type: EXPERIMENTAL
Intervention: Exogenous progesterone
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 30851997

Group type: EXPERIMENTAL
Intervention: Nurse-initiated PCR testing of respiratory specimens
Number of subjects: 181
Study: 28290119

Group type: EXPERIMENTAL
Intervention: Lacosamide 400 mg/day
Number of subjects: 883

Group type: EXPERIMENTAL
Intervention: Lacosamide 200 mg/day
Number of subjects: 883

Group type: COMPARATOR
Intervention: Carbamazepine controlled-release monotherapy
Number of subjects: 883
Study: 26096454

Group type: EXPERIMENTAL
Intervention: Flexible-tip catheter (Cool Flex™)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Rigid-tip catheter
Number of subjects: 7
Study: 23343829

Group type: EXPERIMENTAL
Intervention: Topical lidocaine (1%)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Topical normal saline (0.9% NaCl)
Number of subjects: 11
Study: 21786544

Group type: EXPERIMENTAL
Intervention: Ulinastatin (10,000 U/kg before skin incision, then 5000 U/kg at 1, 2, and 3 days post-operation)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 160
Study: 19621695

Group type: EXPERIMENTAL
Intervention: Continuous hemihepatic inflow occlusion (HHO)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intermittent total hepatic inflow occlusion (THO)
Number of subjects: 80
Study: 16706573

Group type: EXPERIMENTAL
Intervention: epoetin alfa 40,000 units weekly
Number of subjects: 358

Group type: COMPARATOR
Intervention: darbepoetin alfa 200 microg biweekly
Number of subjects: 358
Study: 15807203

Group type: EXPERIMENTAL
Intervention: Lactobacillus supplement (LB)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Fluid milk (L)
Number of subjects: 200
Study: 11520329

Group type: EXPERIMENTAL
Intervention: Tiagabine (TGB) added to baseline Phenytoin (PHT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) added to Phenytoin (PHT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 0
Study: 8993240

Group type: EXPERIMENTAL
Intervention: Heparin-coated ECC
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Uncoated ECC
Number of subjects: 60
Study: 8115196

Group type: EXPERIMENTAL
Intervention: Active distraction technique (blowing out air during injection)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group (no distraction technique)
Number of subjects: 149
Study: 3352906

Group type: EXPERIMENTAL
Intervention: Controlled‐release carbidopa/levodopa preparation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Sinemet
Number of subjects: 0
Study: 31859318

Group type: EXPERIMENTAL
Intervention: sbeIIa/b-AB pudding
Number of subjects: 10

Group type: COMPARATOR
Intervention: WT control pudding
Number of subjects: 10
Study: 30842490

Group type: EXPERIMENTAL
Intervention: Giant viruses (GVs) isolated from environmental samples using co-culture with Acanthomoeba castellanii
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Genomic characterization of isolated GVs
Number of subjects: 20
Study: 27884690

Group type: EXPERIMENTAL
Intervention: Conditioned pain modulation (CPM) using cold pressor pain for 2 minutes
Number of subjects: 2199

Group type: EXPERIMENTAL
Intervention: Pressure pain thresholds (PPTs) recorded over the tibialis anterior muscle and upper trapezius muscle
Number of subjects: 2199

Group type: EXPERIMENTAL
Intervention: Higher level of education
Number of subjects: 2199

Group type: EXPERIMENTAL
Intervention: Premature withdrawal from the cold pressor test
Number of subjects: 2199

Group type: EXPERIMENTAL
Intervention: High visual analog scale score
Number of subjects: 2199
Study: 25454950

Group type: EXPERIMENTAL
Intervention: Blocked training schedule
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Random training schedule
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no additional training)
Number of subjects: 36
Study: 23421331

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 457

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 457
Study: 21614842

Group type: EXPERIMENTAL
Intervention: TAKE (psychologically-informed training including physical activity, nutrition, and psychological issues)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal psychopathology
Number of subjects: 0
Study: 19665260

Group type: EXPERIMENTAL
Intervention: 4% chlorhexidine gluconate
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 70% isopropyl alcohol
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 7.5% to 10% povidone‐iodine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Alcohol added to povidone‐iodine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Any of the preoperative skin‐ and nail‐preparation methods studied
Number of subjects: 28
Study: 16942564

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy 300 IR (Group 3)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Incremental doses up to 500 IR (Groups 1 and 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Constant dose of 500 IR (Group 4)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (Control group not explicitly mentioned)
Number of subjects: 30
Study: 15283055

Group type: EXPERIMENTAL
Intervention: Autologous endometrial coculture (AECC)
Number of subjects: 1030

Group type: COMPARATOR
Intervention: Previous IVF cycles (control)
Number of subjects: 1030
Study: 11421834

Group type: EXPERIMENTAL
Intervention: Preoxygenation with 4 deep breaths of 100% oxygen
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Preoxygenation by breathing oxygen for 1, 3 or 5 min
Number of subjects: 100
Study: 8986522

Group type: EXPERIMENTAL
Intervention: Binge eating group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 8491660

Group type: EXPERIMENTAL
Intervention: Noise condition (audiotape recording of CCU nighttime sounds)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (quiet, no audiotape recording)
Number of subjects: 70
Study: 3760274

Group type: EXPERIMENTAL
Intervention: butyl methoxydibenzoylmethane + padimate O
Number of subjects: 5

Group type: COMPARATOR
Intervention: vehicle + butyl methoxydibenzoylmethane
Number of subjects: 5

Group type: COMPARATOR
Intervention: vehicle + butyl methoxydibenzoylmethane + padimate O
Number of subjects: 5

Group type: COMPARATOR
Intervention: vehicle + padimate O
Number of subjects: 5

Group type: COMPARATOR
Intervention: marketed sunscreen containing padimate O, oxybenzone, and octyl salicylate
Number of subjects: 5
Study: 28325622

Group type: EXPERIMENTAL
Intervention: Hypertonic sea water
Number of subjects: 120

Group type: COMPARATOR
Intervention: Buffered isotonic saline
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline with xylitol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Tap water
Number of subjects: 120
Study: 27487961

Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Comparison of correlations at 120 minutes/day 1
Number of subjects: 200
Study: 24332516

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream once daily for 6 weeks (superficial) or 12 weeks (nodular)
Number of subjects: 501

Group type: COMPARATOR
Intervention: Surgical excision with a 4 mm margin
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Serious adverse events
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Withdrawal due to adverse events
Number of subjects: 501
Study: 22209192

Group type: EXPERIMENTAL
Intervention: Immediate Treatment (IT) group
Number of subjects: 103

Group type: COMPARATOR
Intervention: Delayed Treatment (DT) group
Number of subjects: 103
Study: 21712288

Group type: EXPERIMENTAL
Intervention: Oral morphine (Oramorph)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Oral oxycodone (Oxynorm)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 18435186

Group type: EXPERIMENTAL
Intervention: Group 1 - two-step total-etch adhesive (Single Bond, 3M) + resin composite (Supreme, 3M ESPE)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Group 2 - two-step self-etch adhesive (Clearfil SE, Kuraray) + resin composite
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Group 3 - one-step self-etch adhesive (Xeno III, Dentsply) + resin composite
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (15 teeth without occlusal loading)
Number of subjects: 135
Study: 16567812

Group type: EXPERIMENTAL
Intervention: Insulin/dextrose infusion therapy
Number of subjects: 240
Study: 14527014

Group type: COMPARATOR
Intervention: Subjects who do not exercise routinely
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subjects who do exercise routinely
Number of subjects: 0
Study: 10764173

Group type: EXPERIMENTAL
Intervention: Peroperative morphine titration (3 mg i.v. every 5 or 10 min until respiratory rate decreased)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Postoperative morphine administration in PACU
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Peroperative morphine titration
Number of subjects: 40
Study: 8855488

Group type: EXPERIMENTAL
Intervention: Pyloroplasty
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pyloromyotomy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pylorus stretching
Number of subjects: 30

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 30
Study: 1892076

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 6619041

Group type: EXPERIMENTAL
Intervention: Mezlocillin (18 g/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carbenicillin (18 g/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both antibiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbenicillin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mezlocillin and Carbenicillin
Number of subjects: 0
Study: 31476795

Group type: EXPERIMENTAL
Intervention: Reduced Port Laparoscopic Cholecystectomy (RPLC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard four‐port cholecystectomy (4LP)
Number of subjects: 20
Study: 28459155

Group type: EXPERIMENTAL
Intervention: Individualized, exercise‐focused, self‐management program (MMOVeS)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Exercise information booklet (Control)
Number of subjects: 49
Study: 25935085

Group type: EXPERIMENTAL
Intervention: Veneered zirconia (VZ) crowns made of zirconia frameworks veneered with CAD/CAM‐produced lithium disilicate ceramic
Number of subjects: 60

Group type: COMPARATOR
Intervention: Monolithic lithium disilicate (MLD) crowns
Number of subjects: 60
Study: 25079593

Group type: EXPERIMENTAL
Intervention: Endomyocardial injection of BM cells (100 million, n=19)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (n=9)
Number of subjects: 28
Study: 21990263

Group type: EXPERIMENTAL
Intervention: Substance P (2-8 pmol/min)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Acetylcholine (5-20 µg/min)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Ischaemia-reperfusion injury
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ischaemic preconditioning (local or remote)
Number of subjects: 22
Study: 19549739

Group type: EXPERIMENTAL
Intervention: Nitroglycerin ointment (22.5 mg as Nitro-Bid)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 186
Study: 17762000

Group type: EXPERIMENTAL
Intervention: Screening for type 2 diabetes
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: First screening test
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Final diagnostic test
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Post-diagnosis for screen detected type 2 diabetes
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Intermediate results
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Negative screening results
Number of subjects: 23